Permutable AI reveals worst perceived pharmaceutical companies for governance

May 13, 2024 06:00 PM AEST | By EIN Presswire
 Permutable AI reveals worst perceived pharmaceutical companies for governance
Image source: EIN Presswire

Permutable AI reveals worst perceived pharmaceutical companies for governance based on news sentiment analysis. LONDON, LONDON, UNITED KINGDOM, May 13, 2024 /EINPresswire.com/ -- The pharmaceutical industry is facing a challenging period, marked by increased public scrutiny and regulatory oversight. This week in particular, the industry has been shaken by the news of a fatal incident involving a 16-year-old boy who died after receiving Pfizer’s experimental therapy for Duchenne Muscular Dystrophy.

In light of this, Permutable AI, a company at the forefront of AI-driven data intelligence, has used advanced sentiment analysis to capture the worst perceived pharmaceutical companies for governance.

Key highlights:

- Pfizer has the most negative data score score of -132.54, the lowest among its peers.

- Eli Lilly also shows a notably negative score with a data score of -56.01.

- Johnson & Johnson is also among the bottom pharmaceutical companies perceived for governance with a data score of -34.27.

Summary of sentiment analysis data:

- Rank 1: Pfizer, Average Sentiment: -0.18, Positive Datapoints: 308, Negative Datapoints: 445, Final Data Score: -132.54

- Rank 2: Eli Lilly, Average Sentiment: -0.29, Positive Datapoints: 70, Negative Datapoints: 126, Final Data Score: -56.01

- Rank 3: Johnson & Johnson, Average Sentiment: -0.22, Positive Datapoints: 56, Negative Datapoints: 89, Final Data Score: -32.47

- Rank 4: Eisai, Average Sentiment: -0.35, Positive Datapoints: 15, Negative Datapoints: 31, Final Data Score: -16.16

- Rank 5: Teva Pharmaceuticals, Average Sentiment: -0.13, Positive Datapoints: 53, Negative Datapoints: 69, Final Data Score: -15.94

The role of advanced data intelligence in determining sentiment:

Permutable AI scans over half a million sources daily, providing nuanced and unbiased insights on world events, macro and ESG factors using news sentiment analysis. This real-time data is crucial for companies navigating the complexities of market expectations and regulatory compliance. By leveraging such comprehensive data intelligence, organizations can anticipate changes, manage risks more effectively, and maintain a proactive stance in their strategic planning and communication efforts. This capability is indispensable in today's fast-paced global market where public perception can shift rapidly and have far-reaching impacts on a company's reputation and financial health.

Wilson Chan, CEO of Permutable AI commented, "Recent events have highlighted the complex governance challenges faced by the pharmaceutical industry. Our real-time sentiment analysis is crucial for companies to understand public perception and manage their reputational risk proactively. At Permutable AI, we are committed to providing our clients with the insights they need to navigate these turbulent times effectively."

Talya Stone, CMO of Permutable AI added, "The pharmaceutical industry is at a critical juncture where transparent communication and ethical practices are more important than ever. Our data highlights the need for industry leaders to reinforce trust and confidence with their stakeholders."

Methodology:

Sentiment analysis was performed on the textual data extracted from articles related to each company. This involved assessing the overall sentiment expressed towards a company in the media. The sentiment analysis algorithms considered positive, negative, and neutral sentiments, providing a nuanced view of the public perception.

To delve deeper into sentiment analysis, we identified and quantified specific positive and negative data points within the articles. This allowed us to gauge the factors contributing to a company’s positive or negative sentiment, providing valuable insights into public opinion. The culmination of our analysis is reflected in the end data score, a composite metric synthesizing various factors. This score represents an aggregate evaluation of the company’s perceived performance concerning governance. The methodology ensures a balanced and holistic assessment of each company’s standing within its respective industry.

About Permutable AI:

Founded in 2020, Permutable AI is at the forefront of transforming data intelligence. By leveraging cutting-edge AI technology, Permutable AI enables organizations to access real-time insights, facilitating well-informed strategic decisions in a dynamic world.

For more information, to request more data or explore our data intelligence solutions, please visit our ESG intelligence hub.

Permutable AI
Permutable AI
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.